Normalization of prolactin values in course of therapy with alpha-interferon: Consideration on a patient affected from anti-HCV positive chronic hepatitis and prolactin secernent pituitary microadenoma;Normalizzazione del valori di prolattina in corso di terapia con alfa-interferon: Considerazioni su una paziente affetta da epatite cronica anti-HCV positiva e microadenoma ipofisario prolattino-secernente

Clinica Terapeutica

Volumn 147, Issue 4, 1996, Pages 169-171

  Zennaro, Roberto ^a,b   Petracca, Eugenio Giuseppe ^a,b   Paolini, Rossella ^a,b   Ramazzina, Emilio ^a,b  

^a Ospedale Civile di Rovigo   (Italy)

^b NONE

Author keywords

Alpha interferon; Prolactin

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA;

ADENOMA; ANTINEOPLASTIC AGENTS; FEMALE; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON ALFA-2B; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTIN; TIME FACTORS;

EID: 0029820114     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cesario e coll.: Enhanced yelds of gamma interferon in prolactin treated human peripheral blood mononuclear cells. Proc. Soc. Exp. Biol. Med. 205: 89-95, 1994.
2. Di Bisceglie e coll.: Recombinant Interferon alfa therapy for chronic hepatitis C: a randomized double blind placebo controlled trial. New Engl. J. Med. 321: 1506, 1989.
3. Farci e coll.: A long term study of hepatitis C virus replication in nonA-nonB hepatitis. New Engl. J. Med. 325: 98, 1991.
4. Francis e coll.: Occurrence of hepatitis A, B, nonA-nonB in the United States. Am. J. Med. 76: 69, 1984.
5. Hoofnagle, Di Bisceglie: Antiviral therapy of viral hepatitis. In Galasso, Whitley, Meriga (Eds): Antiviral Agents and Viral Disease of Man. Raven Press, 1990; pagg. 415-459.
6. Hoofnagle e coll.: Treatment of chronic nonA-nonB hepatitis with recombinant human alpha interferon: a preliminary report. New Engl. J. Med. 315: 1575, 1987.
7. Houghton e coll.: Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 14: 381, 1991.
8. Lisker-Melman e coll.: Development of thyroid disease during therapy of chronic viral hepatitis with alpha interferon. Gastroenterology 102, 1992.
9. Renault e Hoofnagle: Side effects of alpha interferon. Seminars in Liver Disease 9: 273, 1989.
10. Vankelekom e coll.: Interferon gamma inhibits stimulated adrenocorticotropin prolactin and Gh secretion in normal rat anterior pituitary cell cultures. Endocrinology 126: 2919, 1990.
11. Walton P.E.R.: TNF-alpha and interferon gamma reduce prolactin realease in vitro. Am. J. Physiol. 259: 672, 1990.
12. Yamaguchi M.: The interferon family stimulates the secretions of prolactin and interleukin-6 by the pituitary gland in vitro. J. Endocrinol. Invest. 14: 457, 1991.
13. Yu Lee Ly e coll.: Interferon regulatory factor 1 is an immediate early gene under transcriptional regulation by prolactin in NB2 T cells. Mol. Cell. Biol. 10: 3087, 1990.